![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1633, 2008-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phospholipase A2 inhibitors in development
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 3, 1997-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phospholipase A2 inhibitors in inflammation
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 7, 2001-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The therapeutic potential for phospholipase A2 inhibitors
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Potential therapeutic uses of phospholipase A2 inhibitors
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phospholipase A2 Inhibitors as Potential Anti-Inflammatory Agents
Current Pharmaceutical Design, Vol. 11, Iss. 10, 2005-04 ,pp. :